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ntermediate strains of MRSA. Suscpetibility pattern has also been
tudied to formulate an effective, inexpensive and easily adminis-
ered empirical therapy for GISA and hGISA.
Methods: Three hundred and Forty seven MRSA isolated from
he clinical specimens of Allied hospitals of AMC/NUST and PAEC
eneral Hospital, Pakistan were subjected to the determination of
ancomycin minimum inhibitory concentration (MIC) and isolates
aving vancomycinMIC≥1g/mlwere subjected todetermination
f Glycopeptide resistance detection (GRD) using Etest. Suscepti-
ility pattern of all the isolates were recorded using Kirby baur
isc diffusion method and MIC for linezolid, daptomycin, chloram-
henicol, minocycline and tigecycline using E-strips. MIC 50 and
IC 90 were calculated
Results: All isolates were sensitive to vancomycin but 197 iso-
ates showed higher MICs and 6 turned out to be heterogenous
lycopeptide intermediate (h GISA) strains.
All the isolated organisms were highly susceptible to linezolid
98.3%), daptomycin (100%), chloramphenicol (96%), minocycline
95.7%) and tigecycline (94.8%).
Conclusion: Signiﬁcant number of isolates having MIC of van-
omycin equal to or more than 1 ug/ml have been isolated and
hese can turn out to be GISA/h GISA. Vancomycin Susceptibility
reakpoints as indicated by CLSI should be reevaluated because
hat doesn’t cover GISA/h GISA isolates. This study suggests that
inezolid, chloramphenicol, minocycline, daptomycin and tigecy-
line have high in vitro efﬁcacy for MRSA infections. Prescribing
ntibiotics other than glycopeptides for MRSA infections will min-
mize the chances of emergence of GISA. Good hospital infection
ontrol measures prove to be the main stay against these infec-
ions because antibiotics can never be an effective alternative to
ood medical practice.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.582
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ossible antagonism with use of ceftaroline and rifampin to
reat methicillin-resistant Staphylococcus aureus infection
. Sundareshan1, J. Modi2, S. Bergman3, J. Koirala1,∗
Southern Illinois University School of Medicine, Springﬁeld, IL, USA
SIU school of medicine, Springﬁeld, il, USA
Southern Illinois University School of Pharmacy, Edwardsville, IL, USA
Background: A 57 year old male was seen in the hospital for
ight shoulder septic arthritic with methicillin resistantStaphy-
ococcus aureus(MRSA). He was treated with arthroscopic
ebridement and intravenous vancomycin until susceptibilities
ere available. The minimum inhibitory concentration (MIC) for
ancomycin was 1.5 mcg/ml, therefore the patient was discharged
ome on 6mg/kg of daptomycin once daily to be given for 4 weeks.
he MIC of daptomycin was not checked at that time. Patient
eturned for follow up in 3 weeks and complained of persistent
ever and low back pain. Blood cultures were drawn that grew
RSA again. Spinal imaging revealed lumbar diskiitis. We present
ere a case where ceftaroline was used for treatment along with
ifampin to treat a highly resistant strain of MRSA and the results
f our laboratory tests.fectious Diseases 16S (2012) e317–e473 e421
Methods: Laboratory tests performed on the isolate of MRSA
from blood cultures revealed a high MIC of daptomycin that was
in the resistant range. There was now also a creep noted in the
MIC of vancomycin. The patient’s therapy was changed to ceftaro-
line which resulted in negative blood cultures within 24 hours
of initiating therapy. Serum inhibitory concentration (SIC) and
serum bactericidal concentration (SBC) were performed using the
patient’s serum prior to a dose of ceftaroline after steady state
(trough). Rifampinwas added to therapy after reviewing the results
as shown below in table 1. The SIC and SBC were repeated when he
was treated with a combination of ceftaroline and rifampin.
Results: MIC using E-
tests(mcg/ml)
SIC SBC
Vancomycin 2.0 Not indicated Not indicated
Daptomycin 3.0 Not indicated Not indicated
Ceftaroline 0.38 1:8 dilution 1:16 dilution
Ceftaroline and rifampin – 1:16 dilution Not achieved
Conclusion: Even with the availability of newer antibiotics in
the United States with activity against MRSA, treatment of MRSA
infections (particularly bloodstream infections) can be suboptimal.
Frequent laboratory testing with SIC and SBC may be necessary
even in theabsenceofnegativebloodcultures as apreemptivemea-
sure to detect impending clinical failure. The SIC and SBC results
with the combination of ceftaroline and rifampin suggest antag-
onism between the two antibiotics. Further laboratory tests are
necessary to establish that. This patient was successfully treated
with quinupristin/dalfopristin for 6 weeks.
http://dx.doi.org/10.1016/j.ijid.2012.05.583
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In vitro antimicrobial activity of colistin in combination with
rifampicin against carbapenem-resistant Acinetobacter bau-
mannii
K. Kongsanae1,∗, P. Naenna1, C. Dhiraputra2, A. Leelarasamee2,
P. Pongpech1
1 Chulalongkorn University, Bangkok, Thailand
2 Mahidol University, Bangkok, Thailand
Background: The in vitro antimicrobial activity of either col-
istin or rifampicin could be increased in the form of combination
between both drugs.
Methods: Thirty carbapenem-resistant A. baumannii isolates
from Bumratnaradoon Hospital between April 2007 and May 2009
were included in this study. Antimicrobial susceptibility tests
were performed by both Kirby-Bauer disk diffusion and Agar dilu-
tion methods. Synergy effect of the combination of colistin and
rifampicin was determined by checkerboard method. In addition,
the time-kill study was used to determine the bactericidal activity
at 0.5×MIC and 1×MIC of either colistin or rifampicin alone and the
combination of both agents. Morphological cell changes of the bac-
teria after growth in the media plus antimicrobials were observed
by using scanning electron microscopy.Results: Susceptibility testing of 12 antimicrobial agents against
carbapenem-resistant A. baumannii showed that all 30 isolates
were resistant to meropenem, imipenem and rifampicin, while
96.7% of these isolates were resistant to cefepime, ceftazidime,
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iperacillin/tazobactam and ciproﬂoxacin. Ninety percent of tested
solates were resistant to amikacin, gentamicin, netilmicin and
obramycin, but 80% were still susceptible to colistin. The MIC
anges for colistin and rifampicin were 1-4 g/ml and 8-16 g/ml,
espectively. MIC50 and MIC90 of colistin were 1, 2 g/ml, respec-
ively and MIC50 and MIC90 of rifampicin were 8 g/ml. The
ynergy study showed the partial synergy effect of colistin when
ombined with rifampicin in 26.7% of the isolates. Bactericidal
ctivity of the combination was observed at all incubation times
y time-kill study. The more damaging effect of the bacterial cell
ysis was clearly observed when the bacteria were grown in the
ombined antimicrobials as compared with the growth in each
ntimicrobial agent.
Conclusion: The in vitro bactericidal activity of the combination
etween colistin and rifampicin was superior to the single agent.
he combination could be a promising alternative for the treatment
f infections due to carbapenem-resistant A. baumannii.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.584
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ntibiotic resistance proﬁles of Staphylococcus aureus blood-
tream isolates
. Prifti, A. Papanagiotou, A. Charalabopoulou, D. Samiotaki, S.
lachos, D. Togkas, E. Kostis ∗, K. Tzanetou
“Alexandra” General Hospital of Athens, Athens, Greece
Background: S. aureus is a common and serious cause of blood-
tream infections with high mortality rate.
Objective: To assess the resistance proﬁles of S. aureus blood-
tream isolates to commonly used antimicrobial agents.
Methods:We retrospectively evaluated all the cases of S. aureus
acteraemia over a two year period from October 2009 through
ctober 2011. Blood samples were routinely obtained in BacTec
ottles (aerobic and anaerobic) and incubated in BACTEC 9050
ystem. Coagulase production, detection of DNase activity onto
NA agar, API STAPH and automated MicroScan system were used
or Staphylococcus identiﬁcation. Antibiotic susceptibility testing
as performed by disc diffusion technique on Mueller-Hinton agar
ccording to CLSI recommendations and MICs were determined by
icroScan system and Etest (AB Biodisk, Solna, Sweden).
Results: During the study period 61 cases of S. aureus
acteraemia were identiﬁed. Of the total bloodstream isolates
6.07% (22/61) were found to be methicillin-resistant (MRSA),
nd 63.93% (39/61) methicillin-susceptible (MSSA). Extended
usceptibility testing of the 61 isolates to erythromycin, clin-
amycin, tetracycline, chloramphenicol, ciproﬂoxacin, rifampicin,
rimethoprim-sulphamethoxazole (SXT), gentamicin, vancomycin,
eicoplanin, linezolid and daptomycin showed the following resis-
ance rates: 72.73%, 68.18%, 63.63%, 18.18%, 63.63%, 0%, 4.54%,
8.18%, 9.09%, 0%, 0%, 0% forMRSAand12.82%, 7.69%, 12.82%, 2.56%,
.13%, 0%, 0%, 0%, 0%, 0%, 0%, 0% for MSSA respectively. Two of the
RSA bloodstream isolates (2/22) showed increased vancomycin
ICs (MICs =3 g/ml conﬁrmed by Etest) according to CLSI new
usceptibility breakpoint (MIC breakpoint for vancomycin has been
educed to 2 g/ml).fectious Diseases 16S (2012) e317–e473
Conclusion: (a) A signiﬁcant rate of S. aureus bloodstream iso-
lates is methicillin-resistant. (b) The MRSA isolates demonstrate
a high resistance rate to erythromycin, clindamycin, tetracycline
and ciproﬂoxacin, whereas a small proportion shows increased
vancomycinMICs. (c)MRSA blood isolates remain daptomycin sus-
ceptible, even with a vancomycin MIC >2 g/ml.
http://dx.doi.org/10.1016/j.ijid.2012.05.585
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Spectrum of causative agents of nosocomial infections (NI) and
their susceptibility to antimicrobials (AM) in multiward clinical
hospital: results of one-year surveillance study
R. Kozlov1,∗, S. Ratchina1, V. Mishchenko1, M. Sukhorukova1, O.
Kretchikova1, E. Korneva2, A. Kuleshov1, D. Gruzdova1
1 Smolensk State Medical Academy, Smolensk, Russian Federation
2 Smolensk regional clinical hospital, Smolensk, Russian Federation
Background: Continued surveillance of etiology and resistance
patterns, along with other measures is essential tool in decreas-
ing NI burden and proper resources allocation. Our study aimed to
determine the spectrumofmicrobial agents causingNI in Smolensk
regional clinical hospital and assess their susceptibility to com-
monly used AM.
Methods: All patients with conﬁrmed diagnosis of NI were
prospectively screened during 12 months period (November 2010-
October 2011). Routine culture and susceptibility testing was
performed for clinical samples by disk-diffusion method. Clinically
signiﬁcant mechanisms of resistance were detected by phenotypic
techniques (ESBLDDST,MBLDDST, cefoxitindisk). Appropriateness
of AM therapy was evaluated in accordance with local guidelines.
Results: A total of 128 patients with 134 NI episodes were
evaluated, etiology was determined in 41/134 (30.6%) of NI cases
(39 patients). Overall 67% of patients were male, mean age was
57.3 years. The most common HI were skin and soft tissue infec-
tions (56%), followed by respiratory tract (22%), urinary tract
(20%) and intraabdominal infections (2%). Seventy one pathogens
were isolated, the most common were the Enterobacteriaceae fam-
ily members – 23 (32.4%), including 15 (65.2%) ESBL producers,
Pseudomonas aeruginosa – 14 (19.7%), including 2 (14.3%) MBL pro-
ducers, Staphylococcus aureus – 11 (15.5%), including 10 (90.9%)
MRSA isolates,Acinetobacter spp.,mainlyAcinetobacter baumannii–
11 (15.5%), Enterococcus spp. – 8 (11.3%), other gram-negative non-
fermentative rods – 2 (2.8%), Streptococcus pyogenes – 1 (1.4%) and
Candida parapsilosis – 1 (1.4%). Empirical AM choice was appropri-
ate in 24% of cases. The regiment of AM therapy was adjusted on
receipt of culture results in 39% of patients and was consider as an
adequate in 54% of cases.
Conclusion: Gram negative rods, particularly Enterobacteri-
aceae and Pseudomonas aeruginosa represented the most common
causative agents of NI in Smolensk regional clinical hospital. High
prevalence of ESBL production andMRSA isolates causes grave con-revision of empirical AM therapy.
http://dx.doi.org/10.1016/j.ijid.2012.05.586
